Abstract
It was 11 March 2020 when the World Health Organization (WHO) declared the name COVID-19 for coronavirus disease and also described it as a pandemic. Till that day 118,000 cases were confirmed of pneumonia with breathing problem throughout the world. At the start of New Year when COVID-19 came into knowledge a few days later, the gene sequencing of the virus was revealed. Today the number of confirmed cases is scary, i.e. 9,472,473 in the whole world and 484,236 deaths have been recorded by WHO till 26 June 2020. WHO's global risk assessment is very high [1]. The report is enlightening the lessons learned by India from the highly affected countries.
Keywords: Death rate, different scenario, fight against COVID-19, remedial action, WHO, risk assessment.
Current Signal Transduction Therapy
Title:How India Fights with COVID-19 Learning from Highly Affected Countries
Volume: 16 Issue: 3
Author(s): Pooja Sharma and Karan Veer*
Affiliation:
- Department of Instrumentation & Control Engineering, Dr. B.R. Ambedkar National Institute of Technology, Jalandhar 144011,India
Keywords: Death rate, different scenario, fight against COVID-19, remedial action, WHO, risk assessment.
Abstract: It was 11 March 2020 when the World Health Organization (WHO) declared the name COVID-19 for coronavirus disease and also described it as a pandemic. Till that day 118,000 cases were confirmed of pneumonia with breathing problem throughout the world. At the start of New Year when COVID-19 came into knowledge a few days later, the gene sequencing of the virus was revealed. Today the number of confirmed cases is scary, i.e. 9,472,473 in the whole world and 484,236 deaths have been recorded by WHO till 26 June 2020. WHO's global risk assessment is very high [1]. The report is enlightening the lessons learned by India from the highly affected countries.
Export Options
About this article
Cite this article as:
Sharma Pooja and Veer Karan *, How India Fights with COVID-19 Learning from Highly Affected Countries, Current Signal Transduction Therapy 2021; 16(3) . https://dx.doi.org/10.2174/1574362415999200807154418
DOI https://dx.doi.org/10.2174/1574362415999200807154418 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Do Genetic Factors Predispose People to COVID-19: A Review Article
Current Molecular Medicine COVID-19 and Neurology: An Emerging Association
Infectious Disorders - Drug Targets Milk Oligosaccharides and Lectins as Candidates for Clinical Trials against Covid-19
Current Nutrition & Food Science Mesenchymal Stem Cells: A Potent Cell Source for COVID-19
Coronaviruses Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
Coronaviruses Coronavirus (COVID - 19): Chemical Entities of Biological Interest
Mini-Reviews in Medicinal Chemistry Management of COVID-19 very Elderly Patients in Nursing Homes and Long-Term Care Facilities: Description of a New Model and Experience in a Medicalized Nursing Home
Coronaviruses Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19
Current Medicinal Chemistry COVID-19 and Renal Diseases: An Update
Current Drug Targets The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Current Rheumatology Reviews Predict Drug-Protein Interaction in Cellular Networking
Current Topics in Medicinal Chemistry <i>In Silico</i> Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19
Coronaviruses The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients
Current Drug Safety Perspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design The Covid-19, Epidemiology, Clinic and Prevention
Current Genomics Prediction of the Functional Roles of Small Molecules in Lipid Metabolism Based on Ensemble Learning
Protein & Peptide Letters Molecular Modeling of Human BAD, a Pro-Apoptotic Bcl-2 Family Member, Integrating Glycolysis and Apoptosis
Protein & Peptide Letters The Role of Chest High Resolution CT and RT-PCR in Diagnosis of Different Stages of Coronavirus (COVID-19) Pneumonia
New Emirates Medical Journal